Platelet-activating factor antagonist BN52021 improves survival in normothermic liver ischemia in rats.
Borobia
F G
FG
Department of General Surgery, Universidad de Barcelona, Spain.
Figueras
J
J
Escriba
J M
JM
Farran
L
L
Rafecas
A
A
Fabregat
J
J
Torras
J
J
Jaurrieta
E
E
D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D004224:Diterpenes; D004305:Dose-Response Relationship, Drug; D046934:Ginkgolides; D006085:Graft Survival / Q000187:drug effects*; D007511:Ischemia; D007783:Lactones / Q000494:pharmacology*; D008102:Liver Circulation; D016031:Liver Transplantation / Q000473:pathology / Q000502:physiology*; D008297:Male; D009336:Necrosis; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors*; D051381:Rats; D017208:Rats, Wistar; D015427:Reperfusion Injury / Q000517:prevention & control
D004224:Diterpenes; D046934:Ginkgolides; D007783:Lactones; D010972:Platelet Activating Factor; C045856:ginkgolide B; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D001663:Bilirubin